Erratum: Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Journal of Clinical Investigation (2017) 127:8 (3075-3089) DOI: 10.1172/JCI89092)

Jia Wang, Peng Cheng, Marat S. Pavlyukov, Hai Yu, Zhuo Zhang, Sung Hak Kim, Mutsuko Minata, Ahmed Mohyeldin, Wanfu Xie, Dongquan Chen, Violaine Goidts, Brendan Frett, Wenhao Hu, Hongyu Li, Yong Jae Shin, Yeri Lee, Do Hyun Nam, Harley I. Kornblum, Maode Wang, Ichiro Nakano

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

At the request of the corresponding author, the JCI is retracting this article. Several concerns were raised regarding the Western blot data in Figures 1J, 2A, 3A, and 4D and Supplemental Figures 3A, 4C, and 6A. After an extensive internal review, it became apparent that errors were introduced during the preparation of the revised figures. Due to loss of confidence in the published figures, the corresponding author requested retraction. No issues have been raised with regard to any of the other data in the paper.

Original languageEnglish (US)
Pages (from-to)6187
Number of pages1
JournalJournal of Clinical Investigation
Volume130
Issue number11
DOIs
StatePublished - Nov 2 2020

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Erratum: Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Journal of Clinical Investigation (2017) 127:8 (3075-3089) DOI: 10.1172/JCI89092)'. Together they form a unique fingerprint.

Cite this